Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Raza, G. S. (Ghulam Shere)"'
Autor:
Raza, G. S. (Ghulam Shere)
Obesity and dyslipidemia are major risk factors for type 2 diabetes, cardiovascular diseases (CVD), cancer, and musculoskeletal disorders. In prevention, the major goal is to limit calorie consumption and to reduce LDL-C and triglyceride. Dietary fib
Externí odkaz:
http://urn.fi/urn:isbn:9789526223032
Autor:
Kamakura, R. (Remi), Raza, G. S. (Ghulam Shere), Mäkilä, E. (Ermei), Riikonen, J. (Joakim), Kovalainen, M. (Miia), Ueta, Y. (Yoichi), Lehto, V.-P. (Vesa-Pekka), Salonen, J. (Jarno), Herzig, K.-H. (Karl-Heinz)
Scope: Nutrients stimulate the secretion of glucagon-like peptide-1 (GLP-1), an incretin hormone, secreted from enteroendocrine L-cells which decreases food intake. Thus, GLP-1 analogs are approved for the treatment of obesity, yet cost and side effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::f305998fac090107f09222146f92fc4f
http://urn.fi/urn:nbn:fi-fe2022021418889
http://urn.fi/urn:nbn:fi-fe2022021418889
Autor:
Kamakura, R. (Remi), Raza, G. S. (Ghulam Shere), Sodum, N. (Nalini), Lehto, V.-P. (Vesa-Pekka), Kovalainen, M. (Miia), Herzig, K.-H. (Karl-Heinz)
Obesity is one of the major global threats to human health and risk factors for cardiometabolic diseases and certain cancers. Glucagon-like peptide-1 (GLP-1) plays a major role in appetite and glucose homeostasis and recently the USFDA approved GLP-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::1e2d974c50f2f76bf47d691525a2185a
http://urn.fi/urn:nbn:fi-fe2023053150732
http://urn.fi/urn:nbn:fi-fe2023053150732
Autor:
Raza, G. S. (Ghulam Shere), Sodum, N. (Nalini), Kaya, Y. (Yagmur), Herzig, K.-H. (Karl-Heinz)
Circadian rhythms significantly affect metabolism, and their disruption leads to cardiometabolic diseases and fibrosis. The clock repressor Rev-Erb is mainly expressed in the liver, heart, lung, adipose tissue, skeletal muscles, and brain, recognized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::68478877dcb8516cbd39bc40dce92851
http://urn.fi/urn:nbn:fi-fe2023070481290
http://urn.fi/urn:nbn:fi-fe2023070481290
Autor:
Saarinen, M. T. (Markku Tapani), Kärkkäinen, O. (Olli), Hanhineva, K. (Kati), Tiihonen, K. (Kirsti), Hibberd, A. (Ashley), Mäkelä, K. A. (Kari Antero), Raza, G. S. (Ghulam Shere), Herzig, K.-H. (Karl-Heinz), Anglenius, H. (Heli)
Polydextrose (PDX) is a branched glucose polymer, utilized as a soluble dietary fiber. Recently, PDX was found to have hypolipidemic effects and effects on the gut microbiota. To investigate these findings more closely, a non-targeted metabolomics ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::57e61994c9558fda8bf19be663143800
http://urn.fi/urn:nbn:fi-fe202103117085
http://urn.fi/urn:nbn:fi-fe202103117085
Autor:
Mutt, S. J. (Shivaprakash Jagalur), Raza, G. S. (Ghulam Shere), Mäkinen, M. J. (Markus J), Keinänen‐Kiukaanniemi, S. (Sirkka), Järvelin, M. (Marjo‐Riitta), Herzig, K. (Karl‐Heinz)
Background: Pandemic vitamin D deficiency is associated with insulin resistance and type 2 diabetes. Vitamin D supplementation has been reported to have improved glucose homeostasis. However, its mechanism to improve insulin sensitivity remains uncle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::3be9ea8ad1cfbf06f5d1519615183469
http://urn.fi/urn:nbn:fi-fe2020052038560
http://urn.fi/urn:nbn:fi-fe2020052038560
Autor:
Egberts, J.-H. (Jan-Hendrik), Raza, G. S. (Ghulam Shere), Wilgus, C. (Cornelia), Teyssen, S. (Stefan), Kiehne, K. (Karlheinz), Herzig, K.-H. (Karl-Heinz)
Alcoholic beverages stimulate pancreatic enzyme secretions by inducing cholecystokinin (CCK) release. CCK is the major stimulatory hormone of pancreatic exocrine secretions, secreted from enteroendocrine I-cells of the intestine. Fermentation product
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::88d002b660201776eb4b0a1fc2d1c3d8
http://urn.fi/urn:nbn:fi-fe2020042923299
http://urn.fi/urn:nbn:fi-fe2020042923299
Autor:
Raza, G. S. (Ghulam Shere), Putaala, H. (Heli), Hibberd, A. A. (Ashley A.), Alhoniemi, E. (Esa), Tiihonen, K. (Kirsti), Mäkelä, K. A. (Kari Antero), Herzig, K.-H. (Karl-Heinz)
Obesity and dyslipidemia are hallmarks of metabolic and cardiovascular diseases. Polydextrose (PDX), a soluble fiber has lipid lowering effects. We hypothesize that PDX reduces triglycerides and cholesterol by influencing gut microbiota, which in tur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::7e27ea4423491f702a93cfc2783d9dbe
http://urn.fi/urn:nbn:fi-fe201708258221
http://urn.fi/urn:nbn:fi-fe201708258221